Clinical Trial Update: Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker [Phase 3]

View source ↗

Summary

Phase 3 trial comparing digoxin versus beta blocker for modulation of left atrial reservoir function in atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Beta-blocker
• DIGOXIN (Digoxin)

Snippet

Sponsor: University of Monastir | Conditions: Atrial Fibrillation, Left Atrial Rhythm | Phase 3 | Status: UNKNOWN